Skip to main
ATRS
ATRS logo

Antares Pharma (ATRS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Antares Pharma (ATRS) Stock

About Antares Pharma (ATRS)

Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.
Market cap$955.06M
Today's volume
Revenue (TTM)
Avg. daily volume4.82M
EBITDA (TTM)
Open
Price / earnings ratio24.28x
Today's range
Debt / equity
52 week range$3.11 - $5.6
5 year debt / equity50.51x
Beta (LTM)0.7x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 10, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 19, 2025, the market cap for ATRS stock is $955.07M

The current P/E ratio for ATRS stock is 24.28

The 52-week high for ATRS stock is $5.60. The current ATRS stock price $undefined is 100.00% below its 52-week high

The 52-week low for ATRS stock is $3.11. The current ATRS stock price $undefined has increased 100.00% from its 52-week low

No, the ATRS stock does not pay dividends to its shareholders

How to buy ATRS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ATRS stock

    Navigate to the Explore page. Then, type ATRS into the search bar. When you see ATRS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ATRS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Antares Pharma Stock Earnings

The value each ATRS share was expected to gain vs. the value that each ATRS share actually gained.

Antares Pharma (ATRS) reported Q4 2021 earnings per share (EPS) of $0.02, beating estimates of $0.01 by 100.00%. In the same quarter last year, Antares Pharma's earnings per share (EPS) was $0.03. Antares Pharma is expected to release next earnings on 05/10/2022, with an earnings per share (EPS) estimate of $0.

Buy Antares Pharma (ATRS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.